[Familial hypocalciuric hypercalcemia with severe neonatal primary hyperparathyroidism (author's transl)].
1982
N Watanabe, and
Y Yamauchi, and
J Matsumoto, and
K Sakaguchi, and
M Fukase, and
M Tsutsumi, and
T Fukami, and
Y Imai, and
T Fujita
UI
MeSH Term
Description
Entries
D006961
Hyperparathyroidism
A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
Adults
Related Publications
N Watanabe, and
Y Yamauchi, and
J Matsumoto, and
K Sakaguchi, and
M Fukase, and
M Tsutsumi, and
T Fukami, and
Y Imai, and
T Fujita
January 2013,
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
N Watanabe, and
Y Yamauchi, and
J Matsumoto, and
K Sakaguchi, and
M Fukase, and
M Tsutsumi, and
T Fukami, and
Y Imai, and
T Fujita